West Pharmaceutical Services Inc Stock News

West Pharmaceutical Services, Inc. (WST) shares closed today at 1.3% below its 52 week high of $475.14, giving the company a market cap of $34B. The stock is currently up 66.6% year-to-date, up 68.6% over the past 12 months, and up 466.3% over the past five years. This week, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 53.2% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 5274.5% The company's stock price performance over the past 12 months beats the peer average by 3450.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 79.1% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

EXTON, Pa., Dec. 27, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will part

West Pharmaceutical Services (WST) Outpaces Stock Market Gains: What You Should Know Nasdaq

West Pharmaceutical Services (WST) closed at $459.84 in the latest trading session, marking a +1.37% move from the prior day.

Alphastar Capital Management LLC raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 3,122.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,498 shares of the medical instruments supplier’s stock after purchasing an additional 18,893 […]

West Pharmaceutical (WST) possesses solid growth attributes, which could help it handily outperform the market.

The global Pharmaceutical Cartridges market was valued at 914.63 Million USD in 2020 and will grow with a CAGR of 5.49% from 2021 to 2027. Worldwide ""Pharmaceutical Cartridges Market"" to develop with a great CAGR over the figure time frame

Related Stocks: CSGP , WST , CPRT , TECH , FTNT , RGS , LSPD , LOPE ,

West Pharma is the IBD Stock Of The Day as shares of the medical supplier approach a buy point. But WST stock could be buyable even now.

Harel Insurance Investments & Financial Services Ltd. reduced its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 88.0% in the third quarter, Holdings Channel reports. The institutional investor owned 99 shares of the medical instruments supplier’s stock after selling 729 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in […]

Kestra Advisory Services LLC raised its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 8.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,661 shares of the medical instruments suppliers stock after buying an additional 201 []

There are 24 stocks on my dividend growth watchlist for December 2021. Nine of the stocks on my watchlist are currently undervalued based on dividend yield theory.

Security Asset Management lowered its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 8.3% during the 3rd quarter, Holdings Channel.com reports. The firm owned 15,226 shares of the medical instruments suppliers stock after selling 1,385 shares during the quarter. West Pharmaceutical Services accounts for about 2.6% of Security Asset Managements investment portfolio, making []